Crossref journal-article
Springer Science and Business Media LLC
Nature Genetics (297)
Bibliography

Pharoah, P. D. P., Antoniou, A., Bobrow, M., Zimmern, R. L., Easton, D. F., & Ponder, B. A. J. (2002). Polygenic susceptibility to breast cancer and implications for prevention. Nature Genetics, 31(1), 33–36.

Authors 6
  1. Paul D.P. Pharoah (first)
  2. Antonis Antoniou (additional)
  3. Martin Bobrow (additional)
  4. Ron L. Zimmern (additional)
  5. Douglas F. Easton (additional)
  6. Bruce A.J. Ponder (additional)
References 20 Referenced 605
  1. Bell, J. The new genetics in clinical practice. Br. Med. J. 316, 618–620 (1998). (10.1136/bmj.316.7131.618) / Br. Med. J. by J Bell (1998)
  2. Beaudet, A.L. 1998 ASHG presidential address. Making genomic medicine a reality. Am. J. Hum. Genet. 64, 1–13 (1999). (10.1086/302217) / Am. J. Hum. Genet. by AL Beaudet (1999)
  3. Friend, S.H. How DNA microarrays and expression profiling will affect clinical practice. Br. Med. J. 319, 1306–1307 (1999). (10.1136/bmj.319.7220.1306) / Br. Med. J. by SH Friend (1999)
  4. Holtzman, N.A. & Marteau, T.M. Will genetics revolutionize medicine? N. Engl. J. Med. 343, 141–144 (2000). (10.1056/NEJM200007133430213) / N. Engl. J. Med. by NA Holtzman (2000)
  5. Vineis, P., Schulte, P. & McMichael, A.J. Misconceptions about the use of genetic tests in populations. Lancet 357, 709–712 (2001). (10.1016/S0140-6736(00)04136-2) / Lancet by P Vineis (2001)
  6. Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78–85 (2000). (10.1056/NEJM200007133430201) / N. Engl. J. Med. by P Lichtenstein (2000)
  7. Peto, J. & Mack, T.M. High constant incidence in twins and other relatives of women with breast cancer. Nature Genet. 26, 411–414 (2000). (10.1038/82533) / Nature Genet. by J Peto (2000)
  8. Easton, D.F. How many more breast cancer predisposition genes are there? Breast Cancer Res. 1, 14–17 (1999). (10.1186/bcr6) / Breast Cancer Res. by DF Easton (1999)
  9. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 in a population based series of breast cancer cases. Br. J. Cancer 83, 1301–1308 (2000). (10.1054/bjoc.2000.1407)
  10. Antoniou, A.C. et al. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population based study. Genet. Epidemiol. 21, 1–18 (2001). (10.1002/gepi.1014) / Genet. Epidemiol. by AC Antoniou (2001)
  11. Antoniou, A.C. et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br. J. Cancer in press (2001). (10.1038/sj.bjc.6600008)
  12. Pharoah, P.D.P. & Mackay, J. Absolute risk of breast cancer in women at increased risk: a more useful clinical measure than relative risk? The Breast 7, 255–259 (1998). (10.1016/S0960-9776(98)90091-1) / The Breast by PDP Pharoah (1998)
  13. Vaittinen, P. & Hemminki, K. Risk factors and age-incidence relationships for contralateral breast cancer. Int. J. Cancer 88, 998–1002 (2000). (10.1002/1097-0215(20001215)88:6<998::AID-IJC25>3.0.CO;2-0) / Int. J. Cancer by P Vaittinen (2000)
  14. Risch, N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer. Epidemiol. Biomarkers Prev. 10, 733–741 (2001). / Cancer. Epidemiol. Biomarkers Prev. by N Risch (2001)
  15. Kelsey, J.L., Gammon, M.D. & John, E.M. Reproductive factors and breast cancer. Epidemiol. Rev. 15, 36–47 (1993). (10.1093/oxfordjournals.epirev.a036115) / Epidemiol. Rev. by JL Kelsey (1993)
  16. Cui, J. et al. After BRCA1 and BRCA2—what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am. J. Hum. Genet. 68, 420–431 (2001). (10.1086/318187) / Am. J. Hum. Genet. by J Cui (2001)
  17. Pharoah, P.D.P., Day, N.E., Duffy, S., Easton, D.F. & Ponder, B.A.J. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int. J. Cancer 71, 800–809 (1997). (10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B) / Int. J. Cancer by PDP Pharoah (1997)
  18. Rose, G. Sick individuals and sick populations. Int. J. Epidemiol. 14, 32–38 (1985). (10.1093/ije/14.1.32) / Int. J. Epidemiol. by G Rose (1985)
  19. Dunning, A.M. et al. A systematic review of genetic polymorphisms and breast cancer risk. Cancer. Epidemiol. Biomarkers Prev. 8, 843–854 (1999). / Cancer. Epidemiol. Biomarkers Prev. by AM Dunning (1999)
  20. Kerlikowske, K., Grady, D., Rubin, S.M., Sandrock, C. & Ernster, V.L. Efficacy of screening mammography. A meta-analysis. J.A.M.A. 273, 149–154 (1995). (10.1001/jama.1995.03520260071035) / J.A.M.A. by K Kerlikowske (1995)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:56 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:16 p.m.)
Indexed 6 days, 17 hours ago (Aug. 29, 2025, 6:26 a.m.)
Issued 23 years, 6 months ago (March 4, 2002)
Published 23 years, 6 months ago (March 4, 2002)
Published Online 23 years, 6 months ago (March 4, 2002)
Published Print 23 years, 4 months ago (May 1, 2002)
Funders 0

None

@article{Pharoah_2002, title={Polygenic susceptibility to breast cancer and implications for prevention}, volume={31}, ISSN={1546-1718}, url={http://dx.doi.org/10.1038/ng853}, DOI={10.1038/ng853}, number={1}, journal={Nature Genetics}, publisher={Springer Science and Business Media LLC}, author={Pharoah, Paul D.P. and Antoniou, Antonis and Bobrow, Martin and Zimmern, Ron L. and Easton, Douglas F. and Ponder, Bruce A.J.}, year={2002}, month=mar, pages={33–36} }